Loading...

NVS

Novartis AG Sponsored ADR · NYSE

Performance

+1.7%

1W

+2.36%

1M

+3.77%

3M

+11.19%

6M

+6.05%

YTD

+13.03%

1Y

Profile

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Investment Analysis Report: Novartis AG (NVS)

Overview

Novartis AG (NVS) is a leading pharmaceutical company in the Health Technology sector, specializing in Major Pharmaceuticals. With a market capitalization of $225.58 billion, Novartis has a strong presence in the industry. In this report, we will conduct a comprehensive analysis of Novartis ...

See more ...

Technical Analysis of NVS 2024-05-31

Overview:

In analyzing the technical indicators for NVS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.

Trend Analy...

See more ...

Recent News & Updates